Cargando…
Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2–4 preventives were not useful: results from the LIBERTY study
OBJECTIVE: To evaluate the effect of erenumab on patient-reported, functional outcomes in patients with episodic migraine (EM) in whom 2–4 preventives were not useful from the Phase 3b LIBERTY study. METHODS: As previously reported, 246 patients with EM with 2–4 prior failed preventives were randomi...
Autores principales: | Lanteri-Minet, Michel, Goadsby, Peter J, Reuter, Uwe, Wen, Shihua, Hours-Zesiger, Peggy, Ferrari, Michel D, Klatt, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053327/ https://www.ncbi.nlm.nih.gov/pubmed/33402419 http://dx.doi.org/10.1136/jnnp-2020-324396 |
Ejemplares similares
-
Two-year efficacy and safety of erenumab in participants with episodic migraine and 2–4 prior preventive treatment failures: results from the LIBERTY study
por: Ferrari, Michel Dominique, et al.
Publicado: (2022) -
Long-term Efficacy and Safety of Erenumab: Results From 64 Weeks of the LIBERTY Study
por: Goadsby, Peter J., et al.
Publicado: (2021) -
Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis
por: Goadsby, Peter J, et al.
Publicado: (2019) -
Headache-related health resource utilisation in chronic and episodic migraine across six countries
por: Sanderson, Joanna C, et al.
Publicado: (2013) -
Non-invasive neuromodulation for migraine and cluster headache: a systematic review of clinical trials
por: Reuter, Uwe, et al.
Publicado: (2019)